New Drug R&D

Minodronic Acid Tablets

Product Name: Minodronic acid
Dosage Forms: Tablet
Strengths: 1 mg, 50 mg (Minodronic acid monohydrate)
Mechanism of Action:
Minodronic acid is a third-generation bisphosphonate drug. Its mechanism of action involves inhibition of farnesyl pyrophosphate synthase activity.
Indications:
It is indicated for the treatment of osteoporosis.
Processing Number: CXHL1200694, CXHL1200695, CXHL1200696
Status: Has gotten the clinical trial permission (2015L03311, 2015L03312, 2015L03141) in October, 2015.
Copyright @ Beijing Hope Pharmaceutical Co., Ltd.